Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction.
ECOR63
EPEC
Escherichia coli Nissle 1917
Intestinal epithelial barrier
Outer membrane vesicles
Tight junctions
Journal
BMC microbiology
ISSN: 1471-2180
Titre abrégé: BMC Microbiol
Pays: England
ID NLM: 100966981
Informations de publication
Date de publication:
17 07 2019
17 07 2019
Historique:
received:
23
05
2018
accepted:
27
06
2019
entrez:
19
7
2019
pubmed:
19
7
2019
medline:
9
4
2020
Statut:
epublish
Résumé
Enteric pathogens have developed mechanisms to disrupt tight junctions and increase gut permeability. Many studies have analysed the ability of live probiotics to protect intestinal epithelial cells against tight junction damage caused by bacterial pathogens. Escherichia coli Nissle 1917 (EcN) is among the probiotics that positively modulates the intestinal epithelial barrier by regulating expression and distribution of tight junction proteins. We previously reported that regulation of ZO-1, claudin-14 and claudin-2 is mediated by EcN secreted factors, either free-released or associated with outer membrane vesicles (OMVs). Factors secreted by commensal ECOR63 elicited comparable effects in intact epithelial T-84 and Caco-2 cell monolayers. Here we analyse the ability of OMVs and soluble secreted factors to protect epithelial barrier function in polarized T-84 and Caco-2 cells infected with enteropathogenic Escherichia coli (EPEC). Transepithelial electrical resistance, paracellular permeability, mRNA levels and subcellular distribution of tight junction proteins were monitored in the absence or presence of EcN and ECOR63 extracellular fractions. EPEC downregulated expression of ZO-1 ZO-2, occludin and claudin-14 and altered the subcellular localization of ZO-1, occludin and F-actin cytoskeleton. OMVs and soluble factors secreted by EcN and ECOR63 counteracted EPEC-altered transepithelial resistance and paracellular permeability, preserved occludin and claudin-14 mRNA levels, retained ZO-1 and occludin at tight junctions in the cell boundaries and ameliorated F-actin disorganization. Redistribution of ZO-1 was not accompanied by changes at mRNA level. This study provides new insights on the role of microbiota secreted factors on the modulation of intestinal tight junctions, expanding their barrier-protective effects against pathogen-induced disruption.
Sections du résumé
BACKGROUND
Enteric pathogens have developed mechanisms to disrupt tight junctions and increase gut permeability. Many studies have analysed the ability of live probiotics to protect intestinal epithelial cells against tight junction damage caused by bacterial pathogens. Escherichia coli Nissle 1917 (EcN) is among the probiotics that positively modulates the intestinal epithelial barrier by regulating expression and distribution of tight junction proteins. We previously reported that regulation of ZO-1, claudin-14 and claudin-2 is mediated by EcN secreted factors, either free-released or associated with outer membrane vesicles (OMVs). Factors secreted by commensal ECOR63 elicited comparable effects in intact epithelial T-84 and Caco-2 cell monolayers.
RESULTS
Here we analyse the ability of OMVs and soluble secreted factors to protect epithelial barrier function in polarized T-84 and Caco-2 cells infected with enteropathogenic Escherichia coli (EPEC). Transepithelial electrical resistance, paracellular permeability, mRNA levels and subcellular distribution of tight junction proteins were monitored in the absence or presence of EcN and ECOR63 extracellular fractions. EPEC downregulated expression of ZO-1 ZO-2, occludin and claudin-14 and altered the subcellular localization of ZO-1, occludin and F-actin cytoskeleton. OMVs and soluble factors secreted by EcN and ECOR63 counteracted EPEC-altered transepithelial resistance and paracellular permeability, preserved occludin and claudin-14 mRNA levels, retained ZO-1 and occludin at tight junctions in the cell boundaries and ameliorated F-actin disorganization. Redistribution of ZO-1 was not accompanied by changes at mRNA level.
CONCLUSION
This study provides new insights on the role of microbiota secreted factors on the modulation of intestinal tight junctions, expanding their barrier-protective effects against pathogen-induced disruption.
Identifiants
pubmed: 31315566
doi: 10.1186/s12866-019-1534-3
pii: 10.1186/s12866-019-1534-3
pmc: PMC6637528
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
166Références
J Allergy Clin Immunol. 2011 Nov;128(5):1067-76.e1-6
pubmed: 21794904
Biosci Biotechnol Biochem. 2015;79(1):130-7
pubmed: 25175351
Ann N Y Acad Sci. 2012 Jul;1258:9-18
pubmed: 22731710
Biochim Biophys Acta. 2008 May;1781(5):270-6
pubmed: 18442488
World J Gastroenterol. 2010 Dec 7;16(45):5759-65
pubmed: 21128328
Front Cell Infect Microbiol. 2015 Mar 25;5:26
pubmed: 25859435
Interdiscip Perspect Infect Dis. 2008;2008:290769
pubmed: 19277100
BMC Microbiol. 2015 Oct 30;15:250
pubmed: 26518156
Eur J Pediatr. 2007 Apr;166(4):311-8
pubmed: 17287932
J Biol Chem. 1951 Nov;193(1):265-75
pubmed: 14907713
Infect Immun. 2008 Apr;76(4):1340-8
pubmed: 18227169
PLoS One. 2007 Dec 12;2(12):e1308
pubmed: 18074031
Nat Rev Immunol. 2014 Mar;14(3):141-53
pubmed: 24566914
Front Microbiol. 2016 May 11;7:705
pubmed: 27242727
Infect Immun. 1993 Jul;61(7):2755-62
pubmed: 8514377
Cell Commun Adhes. 2012 Oct;19(5-6):63-8
pubmed: 23181544
J Clin Invest. 2001 Mar;107(5):539-48
pubmed: 11238553
Gut. 2002 May;50 Suppl 3:III54-9
pubmed: 11953334
Tissue Barriers. 2013 Jul 1;1(3):e24978
pubmed: 24478939
Biochim Biophys Acta. 2008 Mar;1778(3):729-56
pubmed: 17950242
Cell Microbiol. 2007 Mar;9(3):804-16
pubmed: 17087734
J Bacteriol. 1984 Feb;157(2):690-3
pubmed: 6363394
Gastroenterology. 2009 Jul;137(1):209-20
pubmed: 19303021
Front Microbiol. 2017 Jul 11;8:1274
pubmed: 28744268
PLoS One. 2016 Aug 03;11(8):e0160374
pubmed: 27487076
Inflammation. 2012 Feb;35(1):23-32
pubmed: 21170673
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Microbiology. 2010 Nov;156(Pt 11):3232-3242
pubmed: 20864471
Curr Infect Dis Rep. 2006 Mar;8(2):103-9
pubmed: 16524546
Cell Microbiol. 2010 Jan;12(1):31-41
pubmed: 19712078
Biochim Biophys Acta. 2008 Mar;1778(3):588-600
pubmed: 17916321
J Gastroenterol. 2016 Aug;51(8):768-78
pubmed: 27048502
Pathol Int. 2008 Mar;58(3):156-63
pubmed: 18251778
Am J Physiol. 1995 Feb;268(2 Pt 1):G374-9
pubmed: 7864134
Cell Microbiol. 2004 Aug;6(8):783-93
pubmed: 15236645
Ann N Y Acad Sci. 2009 May;1165:169-74
pubmed: 19538303
Cold Spring Harb Perspect Med. 2013 Mar 01;3(3):a010074
pubmed: 23457295
Biochem J. 2006 Jan 1;393(Pt 1):69-77
pubmed: 16134968
Nat Rev Immunol. 2009 Nov;9(11):799-809
pubmed: 19855405
Mol Cell Biol. 2012 Jan;32(2):242-50
pubmed: 22083955
Cell Microbiol. 2000 Aug;2(4):305-15
pubmed: 11207587
Front Cell Infect Microbiol. 2016 Aug 24;6:87
pubmed: 27606286
Gut. 2004 Nov;53(11):1617-23
pubmed: 15479682
Int J Colorectal Dis. 2012 Apr;27(4):467-74
pubmed: 22130826
Front Microbiol. 2016 Dec 15;7:1981
pubmed: 28018313
Gastroenterology. 1997 Dec;113(6):1873-82
pubmed: 9394726
Intest Res. 2015 Jan;13(1):11-8
pubmed: 25691839
Front Microbiol. 2015 Nov 18;6:1285
pubmed: 26635753
Mucosal Immunol. 2014 Mar;7(2):369-78
pubmed: 23900194
PLoS One. 2013;8(3):e58606
pubmed: 23505542
Nutr Rev. 2010 Aug;68(8):459-64
pubmed: 20646223
J Physiol. 2012 Mar 1;590(5):1035-44
pubmed: 22219336
J Clin Gastroenterol. 2015 Nov-Dec;49 Suppl 1:S50-5
pubmed: 26447965
Proteomics. 2014 Feb;14(2-3):222-9
pubmed: 24307187
BMC Microbiol. 2009 Mar 31;9:63
pubmed: 19331693
Cell Mol Life Sci. 2013 Feb;70(4):631-59
pubmed: 22782113
Nat Rev Immunol. 2015 Jun;15(6):375-87
pubmed: 25976515